Sign in

Private company

GI Innovation

GI Innovation is a South Korean company.1

주식회사 GI이노베이션(영어: GI Innovation Inc.)은 서울특별시 송파구 송파대로 167 비동 1014호(문정동, 문정역 테라타워)에 본사를 둔 이중융합 단백질기술 'GI-SMART TM'을 기반으로 면역치료제 연구개발 기업이다.2 From the Korean Wikipedia, CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

See how the biggest companies compare on our leaderboards

Calendar

Drug trials and FDA: coming up

  1. Feb 2027Phase 1/2 trial readout expected Phase 1/2 trial of GI-108 in Advanced Solid Tumor: primary completion expected Feb 2027 (ClinicalTrials.gov NCT07172802).3

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3